Resolution Statement – 29938-20 Ackroyd v Lytham St Annes
Express
Summary of Complaint
1. Peter Ackroyd complained to the Independent Press
Standards Organisation that Lytham St Annes Express breached Clause 1
(Accuracy) of the Editors’ Code of Practice in an reader’s letter headlined
“Covid vaccine is being rushed out”, published on 10 December 2020.
2. The letter had been submitted by a reader, and stated
that the “Pfizer/BioNTech vaccine and the Moderna vaccine are experimental mRNA
vaccines” and described them as “rushed”. It reported that “the phase three trial
of safety and efficacy testing is still ongoing”, and that phase three would
not be complete “until 24 months after vaccination”. It said the people who had
wanted the vaccine were “literally human guinea pigs who are volunteering to be
experimented upon”.
3. The complainant said that the letter was inaccurate in
breach of Clause 1 as the safety and efficacy phase trials were complete at the
time of publication, and therefore it was inaccurate to state that people who
wanted the vaccine would be “human guinea pigs”. He also said that it was
misleading to state that it was “rushed” as whilst the vaccine had been
approved quickly, there was no suggestion it had been done in a hurried manner, or that it had suffered
as a result of the speed with which it had been produced. He also said it was
misleading to report that it was experimental, as it had been approved by the
Medicines and Healthcare products Regulatory Agency.
4. The publication did not accept a breach of the Code. It
said that readers’ letters are clearly marked and that the page acts as a forum
for readers’ opinions. It said it did not wish to censor the opinions of
readers, but offered the complainant the opportunity to write a rebuttal
letter.
Relevant Code Provisions
Clause 1 (Accuracy)
i) The Press must take care not to publish inaccurate,
misleading or distorted information or images, including headlines not
supported by the text.
ii) A significant inaccuracy, misleading statement or
distortion must be corrected, promptly and with due prominence, and — where
appropriate — an apology published. In cases involving IPSO, due prominence
should be as required by the regulator.
iii) A fair opportunity to reply to significant inaccuracies
should be given, when reasonably called for.
iv) The Press, while free to editorialise and campaign, must
distinguish clearly between comment, conjecture and fact.
Mediated Outcome
5. The complaint was not resolved through direct
correspondence between the parties. IPSO therefore began an investigation into
the matter.
6. During IPSO’s investigation the publication offered to print
the following correction:
In a letter published on December 10, 2020 (Covid vaccine is
being rushed out) the letter writer claimed the Pfizer/BioNTeach and Moderna
vaccines had been “rushed out” and were “experimental”.
We have been asked to point out that, according to the
independent Oxford Vaccine Knowledge Project, this is not the case and both
vaccines have been through a very extensive testing process, involving tests on
10,000s of people across five continents.
The letter writer also claimed phase three of the safety and
efficacy trial of the Pfizer vaccine was still underway and would continue for
a further 24 months.
Pfizer's final phase three safety and efficacy results were
actually published by the New England Journal of Medicine on the same day as
the letter appeared in the Express.
Pfizer plans to continue its study to collect safety and
long-term outcomes data from participants for a full two years. It also intends
to submit its data for peer review. Both of these processes sit outside of the
phase three trial period.
The letter writer also described anyone having the vaccine
as “human guinea pigs who are volunteering to be experimented upon.”
We have been asked to make clear that, according to the
Oxford Vaccine Knowledge Project, the Covid-19 vaccines currently approved have
been thoroughly reviewed by the Medicines and Healthcare Products Regulatory
Agency.
This authorisation means people getting the vaccine can be
assured they are not considered “guinea pigs” in any way.
7. The complainant said that this would resolve the matter
to his satisfaction.
8. As the complaint was successfully mediated, the
Complaints Committee did not make a determination as to whether there had been
any breach of the Code.
Date complaint received: 17/12/2020
Date complaint concluded by IPSO: 20/01/2021
Back to ruling listing